Authors:
Paoletti, LC
Rench, MA
Kasper, DL
Molrine, D
Ambrosino, D
Baker, CJ
Citation: Lc. Paoletti et al., Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines, INFEC IMMUN, 69(11), 2001, pp. 6696-6701
Authors:
Zaleznik, DF
Rench, MA
Hillier, S
Krohn, MA
Platt, R
Lee, MLT
Flores, AE
Ferrieri, P
Baker, CJ
Citation: Df. Zaleznik et al., Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups, CLIN INF D, 30(2), 2000, pp. 276-281
Authors:
Moylett, EH
Fernandez, M
Rench, MA
Hickman, ME
Baker, CJ
Citation: Eh. Moylett et al., A 5-year review of recurrent group B Streptococcal disease: Lessons from twin infants, CLIN INF D, 30(2), 2000, pp. 282-287
Authors:
Baker, CJ
Paoletti, LC
Rench, MA
Guttormsen, HK
Carey, VJ
Hickman, ME
Kasper, DL
Citation: Cj. Baker et al., Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women, J INFEC DIS, 182(4), 2000, pp. 1129-1138
Authors:
Baker, CJ
Paoletti, LC
Wessels, MR
Guttormsen, HK
Rench, MA
Hickman, ME
Kasper, DL
Citation: Cj. Baker et al., Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib, J INFEC DIS, 179(1), 1999, pp. 142-150